| A Randomized, Open-label, Multicentral, Two Arm, Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet) |
Ongoing |
Deferasirox / Defearisox new formula |
2 |
CICL670F2201 |
King Khalid University Hospital (Riyadh), King Fahad University Hospital (Al-Khobar), King Abdulaziz University Hospital (Jeddah), King Fahad Specialist Hospital (Dammam) |
| Daily practice treatment and Influence of Visanne on the patient Assessment of quality of life parameters |
Completed |
Visanne |
4 |
VS1101 |
King Khalid University Hospital (Riyadh), Soliman Fakeeh Hospital (Jeddah) |
| An Open-Label, Randomized Naturalistic Study to Evaluate the Incidence of Hypoglycemia Comparing Sitagliptin With Sulfonylurea Treatment in Patients With Type 2 Diabetes During Ramadan Fasting |
Completed |
Sitagliptin |
4 |
MK0431-263 |
Al-Noor Specialist Hospital (Makkah), Armed Forces Hospital (Al-Hada), King Fahad University Hospital (Al-Khobar), Riyadh Care Hospital, Al Alam Medical Center (Riyadh) |
| A 20-week Study Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients Uncontrolled on NPH Insulin |
Completed |
BIAsp 30 / Metformin |
4 |
BIAsp 3968 |
King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz University Hospital (Jeddah), Armed Forces Hospital (Al-Hada) |
| A multicentre, prospective observational cohort study to assess the effects of vildagliptin relative to sulphonylurea as dual therapy with metformin (or as monotherapy) in Muslim patients with type 2 diabetes fasting during Ramadan |
Completed |
Vildagliptin / Sulphonylurea / Metformin |
4 |
CLAF237A-MAX-AE-02 |
Soliman Fakeeh Hospital (Jeddah) |
| A Multicenter, Prospective, Observational, Non-Interventional Cohort Study Evaluating On-Treatment Predictors of Response in Subjects With HBeAg Positive and HBeAg Negative Chronic Hepatitis B Receiving Therapy With PEGASYS(R) (Peginterferon Alfa-2a 40KD) |
Completed |
Pegasys |
4 |
MV22009 |
King Fahad University Hospital (Al-Khobar), Armed Forces Hospital (Kharj) |
| UNraveling nAMD real life Clinical management and Outcome with intraVitrEal Ranibizumab injection – A retrospective analysis (UNCOVER) |
Completed |
Ranibizumab |
4 |
CRFB0021 |
King Khaled Eye Specialist Hospital (Riyadh) |
| A double blind, Double Dummy, Randomized, Multi-Centre study to assess the tolerability and Efficacy Profile of Vildagliptin Compared to Gliclazide as Dual Therapy with Metformin in Muslim Patients with Type 2 Diabetes Fasting During Ramadan. |
Completed |
Vildagliptin /Gliclazide / Metformin |
4 |
CLAF237A2411 |
King Fahad University Hospital (Al-Khobar)_ King Abdulaziz Medical City NG (Riyadh) |
| A Phase III, Multicentre, International, Randomised, Parallel Group, Double Blind Cardiovascular Safety Study of BI 10773 (10 mg and 25 mg Administered Orally Once Daily) Compared to Usual Care in Type 2 Diabetes Mellitus Patients With Increased Cardiovascular Risk |
Completed |
BI 10773 |
3 |
1245.25 |
King Fahad Medical City (Riyadh) |
| Global Study to Assess the Addition of Bevacizumab to Carboplatin and Paclitaxel as Front-line Treatment of Epithelial Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Carcinoma |
Completed |
Bevacizumab |
3 |
MO22923 |
King Fahad Medical City (Riyadh)_ King Fahad Specialist Hospital (Dammam) |
